03534nas a2200289 4500008004100000245009300041210006900134260001500203300001000218490000600228520267600234653001602910653001502926653001602941653001402957653001702971653001602988100002203004700002703026700002903053700002003082700001903102700001903121700002003140700002503160856005903185 2020 eng d00aPharmacist Privilege in Saudi Arabia: Pharmacist Prescribing and Therapeutic Interchange0 aPharmacist Privilege in Saudi Arabia Pharmacist Prescribing and  cMarch 2020 a50-540 v63 a

Objectives: To survey the pharmacist privilege in Saudi Arabia with an emphasis on pharmacist prescribing and therapeutic interchange. Methods: This is a 4-month cross-sectional survey of pharmacists privilege in Saudi Arabia. The study consists of two parts: the first part collects demographic information and the second part comprises 28 questions divided into four domains. These domains were derived from the previous literature and from the standards and regulations described by the American Society of Health-System Pharmacists (ASHP). The domains were privilege management and resources, pharmacist prescribing and therapeutic interchange, clinical and administration privilege, drug monitoring and healthcare education. We used 5-point Likert response scale system with closeand open-ended questions to obtain responses. The questionnaire was distributed in an electronic format to the director of pharmacy of various hospitals, deputy director, pharmacy quality management, clinical pharmacy coordinators, or any pharmacist assigned on behalf of hospital’s director of pharmacy. The study discussed and analyzed pharmacist privilege in Saudi Arabia with an emphasis on pharmacist prescribing and therapeutic interchange. All data were obtained through the Survey Monkey system. Results: The survey was distributed to 36 hospitals. The pharmacist privilege of prescribing was available only at 12 (32.14%) hospitals. over-the-counter (OTC) medications (19 (90.48%)) and vitamins (14 (66.67%)) were most of the medications with pharmacist privilege of prescribing followed by minerals (11 (52.38%)) and electrolytes (10 (47.62%)), whereas NSAIDs (23 (63.89%)), Vitamins (19 (52.78%)), electrolytes (17 (47.22%)) and antihistamine (15 (41.67%)) were through therapeutic interchange program. Most of the pharmacists prescribing medication was through ambulatory care clinic (19 (52.78%)) and when prescription was cosigned by the physician (19 (52.78%)). The average score of pharmacist privilege in the hospital’s computerized physician order entry (CPOE) was 3.17 (63.46%), whereas the average score of pharmacist privilege in the hospital’s CPOE alerting system was 2.97 (59.46%). Conclusion: In the Kingdom of Saudi Arabia, pharmacist privilege in prescribing medications is very low. Most of the medications prescribed by the pharmacist were OTC drugs. Thepharmacist privilege in the Computerized Physician Order Entry is not adequate. We highly recommend the implementation of a comprehensive pharmacist privilege system and regulations ed in Saudi Arabia.

10aInterchange10aPharmacist10aPrescribing10aPrivilege10aSaudi Arabia10aTherapeutic1 aAl-Otaibi, Faisal1 aImam, Mohamed, Soliman1 aAhmed, Randa, Mansour Ab1 aAlotaibi, Amsha1 aAlotaibi, Asma1 aAlotaibi, Amal1 aAlsuwaid, Wesam1 aAlomi, Yousef, Ahmed uhttp://ptbreports.org/article/2020/6/2/105530ptb202069